Arthrosurface Gains FDA Clearance for OVOMotion Stemless Total Shoulder

Arthrosurface received FDA 510(k) clearance to market the OVOMotion™ Shoulder Arthroplasty system, a stemless total shoulder to treat damage from arthritis, trauma or Avascular Necrosis.

The design combines anatomic restoration with an aspherical head, and is cleared for use with the company's Inlay Glenoid system. Studies have shown that the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us